Financials
| Results for the Six Months ended 30 June 2019 | Sep. 18, 2019 |
| Trading Update | Jul. 17, 2019 |
| Annual Report | Jun. 19, 2019 |
| Final Results for Year Ended 31 December 2018 | Apr. 24, 2019 |
| Trading Update | Jan. 15, 2019 |
| Results for the Half Year ended 30 June 2018 | Sep. 24, 2018 |
| Results for the Half Year ended 30 June 2018 | Sep. 24, 2018 |
Proxies
| Result of AGM | Nov. 01, 2019 |
| Notification of AGM and Audit Declaration | Oct. 08, 2019 |
| Result of AGM | Oct. 31, 2018 |
| Result of AGM | Oct. 31, 2018 |
| Notice of AGM | Oct. 08, 2018 |
| Notice of AGM | Oct. 08, 2018 |
| Notice of AGM and Annual Report | Apr. 30, 2018 |
Ownership Update
| Grant Of Options | Jan. 24, 2020 |
| Holding(s) in Company | Jan. 22, 2020 |
| Holding(s) in Company | Jan. 22, 2020 |
| Holding(s) in Company | Jan. 22, 2020 |
| Director/PCA transaction initial notification | Dec. 16, 2019 |
| Director Dealings | Mar. 19, 2019 |
| Director Dealings | Dec. 17, 2018 |
Announcements
| License Agreement with Allogene Therapeutics | Mar. 24, 2020 |
| Consolidation of Trading Lines | Feb. 21, 2020 |
| AIM Block Admission Return / Total Voting Rights | Feb. 20, 2020 |
| MaxCyte to Present at BIO CEO & Investor Conf | Feb. 05, 2020 |
| Trading Update | Jan. 20, 2020 |
| New Executive Vice President and Trial Update | Dec. 19, 2019 |
| Agreement with KSQ Therapeutics | Dec. 04, 2019 |